EPIRUS Biopharmaceuticals, Inc. Accumulated Other Comprehensive Income
EPIRUS Biopharmaceuticals, Inc. had Accumulated Other Comprehensive Income of $39.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2016-05-10
- 2016-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $39.00K.
- 2015-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$23.00K.
- 2015-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$8.00K.
- 2013-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2016-03-31 | $39.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$23.00K 10-Q · filed 2016-05-10 |
| 2015-09-30 | -$8.00K 10-Q · filed 2015-11-16 |
| 2013-06-30 | -$1.00K 10-Q · filed 2013-08-05 |
| 2013-03-31 | $4.00K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $10.00K 10-K · filed 2014-03-14 |
| 2012-09-30 | $10.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $7.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $14.00K 10-Q · filed 2012-05-04 |
| 2011-12-31 | -$8.00K 10-K · filed 2013-03-07 |
| 2011-09-30 | -$30.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $5.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | -$20.00K 10-K · filed 2012-03-09 |